Recent Cancer Council NSW grant outcomes
2010
Bendall L
Westmead Millennium Institute
The role of sphingosine-1-phosphate in haematopoietic stem cell egress from the bone marrow
deFazio A
Westmead Millennium Institute
Pathways of malignant progression in ovarian cancer
Lyons G
University of Sydney
Restoring epithelial differentiation to squamous cell carcinomas
2009
New Project Grants
Bebawy M
University of Sydney
Microparticle-mediated transfer of p-glycoprotein in conferring multi-drug resistance in cancer
Byrne J
University of Sydney
The molecular basis of cell transformation produced by tpd52 over-expression
Chen S
Westmead Hospital
Randomised trial of diagnostic strategies for invasive aspergillosis in at-risk haematology patients: funding extension
Fabbro M
University of Sydney
Dynamin inhibitors as new anti-cancer drugs
Goldstein D
University of Sydney
Lap07: randomised multicentre phase iiistudy in patients with locally advanced adenocarinoma of the pancreas: gemcitabine – with or without chemoradiotherapy and with or without erlotinib
Gottlieb D
University of Sydney
Adoptive immunotherapy for the prevention of varicella-zoster virus reactivation post stem cell transplant
Hart D
Molecular and Microbial Sciences
University of Sydney
RNA loading of tumor associated antigens and the activation of blood dendritic cells for prostate cancer immunotherapy
Jolly C
University of Sydney
Understanding aid-induced cancer: unravelling complex mutation and repair pathways
McDonald K
University of Sydney
The role of iqgap1 in actively migrating glioma cells and its regulation by mir-124
Murray M
University of Sydney
Development of personalised dosage protocols for tyrosine kinase inhibitors in oncology patients
Naylor M
Faculty of Veterinary Science
University of Sydney
Role of beta1 integrin in prostate development and carcinogenesis
O’Neill G
University of Sydney
The signalling switch function of the pro-metastatic, adhesion adaptor protein hef1
Young J
University of Sydney
Quality of life outcomes and cost effectiveness of pelvic exenteration for people with advanced rectal cancer
New Innovator Grants
Xue A and Smith R
Kolling Institute
Discovery of prognostic serum biomarkers for pancreatic cancer
Richardson D
University of Sydney
Development of novel and potent anti-tumour agents for the treatment of pancreatic cancer
2008
New Strategic Research Partnership Grants
George J
Westmead Hospital
Epidemiology, prevention and management of liver cancer in NSW
New Projects
Armstrong B
School of Public Health
Prostate specific antigen, sun and vitamin D
Boyer M
Central Clinical School
Trialling adding nitroglycerin to first line chemotherapy in advanced non-small call lung cancer
Clifton-Bligh R
Kolling Institute of Medical Research
The PPAR gene and thyroid cancer
Crossley M
School of Molecular and Microbial Sciences
Gene regulatory proteins associated with lymphoma
Damian D
Department of Dermatology, Royal Prince Alfred Hospital
Nicotinamide protection from skin cancer development
Reeve V
Faculty of Veterinary Science
Oestrogen protection from ultraviolet radiation and skin cancer
Suchowerska N
Department of Radiation Oncology, Royal Prince Alfred Hospital
A new radiobiological model for radiotherapy
Trevena L
School of Public Health
Preventing cervical cancer: a web-based toolkit for young women